Mannatech (NASDAQ:MTEX) Stock Passes Below 200-Day Moving Average – Should You Sell?

Shares of Mannatech, Incorporated (NASDAQ:MTEX) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $8.21 and traded as low as $5.78. Mannatech shares last traded at $5.78, with a volume of 4,163 shares traded.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Mannatech in a research report on Monday, December 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Mannatech Trading Down 15.0%

The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.56 and a current ratio of 1.13. The firm has a market cap of $10.98 million, a price-to-earnings ratio of -6.72 and a beta of 0.81. The business has a fifty day simple moving average of $7.05 and a 200-day simple moving average of $8.21.

Mannatech Company Profile

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.